Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJ1YE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,814
Award facts
- Contract value 100% obligated
- $59,813.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $59,813.93 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, reflecting the Defense Health Agency's ongoing pharmaceutical supply requirements for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor headquartered in Pennsylvania and serves as a critical federal vendor for military and veteran healthcare systems, having demonstrated significant capacity to compete and deliver medical products across multiple therapeutic domains through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJ1YE?
SPE2DB25FJ1YE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FJ1YE worth?
The government has obligated $59,814 on SPE2DB25FJ1YE.
Is contract SPE2DB25FJ1YE an order under another contract?
Yes. SPE2DB25FJ1YE is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ1YE competed?
The extent of competition for SPE2DB25FJ1YE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award